covid pfizer - Search News

Order byBest matchMost fresh

FDA, COVID and vaccine

FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines

The U.S. Food and Drug Administration (FDA) has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines.

· 1d · on MSN

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation

· 1d · on MSN

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

· 1d

New Trump vaccine policy limits access to COVID shots

The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending more data on everyone else — raising questions about whether some p...

· 10h

FDA panel recommends keeping COVID shots targeted to same strain as last year

· 1d

FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules

· 1d

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?

Public trust in vaccination has declined, potentially impacting other vital immunization programs.

· 15h

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

· 14h

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

GOP Senate report finds Biden health officials misled public about risks of myocarditis from COVID-19 vaccines

The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.

3hon MSN

U.S. reports cases of new COVID variant NB.1.8.1 behind surge in China

Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared to other strains on the rise, but it does have a greater ability to bind to human cells, suggesting it could be more transmissible.

News and Sentinel2m

FDA panel is split on updates to COVID shots as questions loom for fall vaccinations

Government advisers were split Thursday on whether drugmakers need to update their COVID-19 vaccines for next season, a decision overshadowed by confusion over a new Trump administration policy that may limit which Americans can get the shots.

Pfizer scientist claimed COVID vax results being delayed until after 2020 election ‘wasn’t a coincidence’: House GOP panel

The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr. Philip Dormitzer, may have “conspired to withhold public

2don MSN

FDA sets new COVID booster guidelines for healthy adults under 65

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

AARP3d

Third COVID Vaccine Gets Approved for Adults 65 and Over

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.

Pfizer: Better To Face The Harsh Reality Than Continue Waiting

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click to find out why PFE stock is a Hold.